RPL36AP10

Across TCGA pan-cancer cohorts, RPL36AP10 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL36AP10’s most consistent transcriptional readouts.

The strongest signal is observed in esophageal carcinoma (ESCA), where RPL36AP10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL36AP10 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

ESCA, BRCA, and LUSC are the cancer types where RPL36AP10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL36AP10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
ESCA	All	II,III,IV	+0.385	.001	2	view →
BRCA	All	III,IV	+0.066	.048	2	view →
LUSC	Male	II,III,IV	−0.061	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL36AP10–ESCA

Open the ESCA breakdown →